Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02662010 · ClinicalTrials.gov registry record
The Relationship Between Advanced Glycation Endproducts and Diabetes
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 157
- Enrollment target
NCT02662010: Completed study, sponsored by University of Colorado, Denver.
NCT02662010 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 157 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02662010 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 157 participants
- Enrollment target
Study Summary
The overall purpose of this COMIRB application is to perform a cross-sectional pilot study to aid in the design of a prospective epidemiologic study for an NIH grant application. The long term goal of this research is to determine if AGEs are predictors of glycemic control and the development of diabetic retinopathy in patients with T2DM. Understanding these relationships could lead to a prospective prediction of the onset/worsening of diabetic retinopathy in T2DM patients and in pre-diabetic individuals.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2016-03 |
| Est. Completion | 2020-01-17 |
What the finished NCT02662010 record still lists
NCT02662010 is an observational study that tracks outcomes without assigning an intervention. The registered 157 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02662010 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02662010 about?
NCT02662010 is a clinical study titled "The Relationship Between Advanced Glycation Endproducts and Diabetes". The overall purpose of this COMIRB application is to perform a cross-sectional pilot study to aid in the design of a prospective epidemiologic study for an NIH grant application. The long term goal of this research is to determine if AGEs are predictors of glycemic control and the development of dia...
What is the current status of trial NCT02662010?
This trial is currently completed. The enrollment target is 157 participants. The study started on 2016-03. Estimated completion is 2020-01-17.
Who is sponsoring clinical trial NCT02662010?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05052541 · 157 participants · Phase 3
Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
- NCT05076942 · 157 participants · Phase 2
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
- NCT06396598 · 157 participants · NA
Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
- NCT06655246 · 157 participants · Phase 1
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia